St. Jude Medical Receives FDA Approval of TactiCath Quartz Contact Force Ablation Catheter for Treatment of Atrial ...

St. Jude Medical, Inc. , a global medical device company, today announced U.S. Food and Drug Administration approval of its TactiCath™ Quartz irrigated ablation catheter, the company’s newest technology that gives physicians a real-time, objective measure of the force that the catheter applies to a patient’s heart wall during an ablation procedure.



from Content Keyword RSS http://ift.tt/1yFFi8D

via IFTTT